Rachana Pradhan - KFF Health News
-
The bottleneck caused by states’ reevaluation of Medicaid enrollees has swept up low-income families that rely on other safety-net services. -
Anti-abortion groups have lost seven consecutive elections on state ballot measures about abortion. They say they’re unfazed and plan to keep focusing on lawmakers and state courts to notch wins.
-
A KFF survey of employer health benefits shows that 28% of large U.S. companies have limited or no access to abortion under company health insurance.
-
The Biden administration unveiled the first 10 drugs subject to price negotiations, taking a swipe at the pharmaceutical industry. But what does it mean for patients?
-
The Centers for Medicare & Medicaid Services backed off from a plan that could have curtailed access to a type of surgery known as DIEP flap. Breast cancer patient advocates are relieved.
-
Family planning clinics are getting caught between state abortion bans and a federal requirement to refer patients for abortion care on request.
-
The May 11 expiration of the federal government’s pandemic emergency declaration will affect patient care across a broad range of settings, including telemedicine, hospitals, and nursing homes.
-
Since 2017, Medicaid expansion has been adopted in seven states where a question was placed directly on the ballot. But campaign leaders say that strategy may not work in Florida.
-
Private equity-backed Headlands Research heralded its COVID vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.
-
The pandemic has overwhelmed understaffed state Medicaid agencies, and as Biden's COVID-19 public health emergency declaration ends, low-income people could find it even harder to get coverage.
